Table 4 Predictors of good prognosis in the cytokines/chemokines measurement group (N = 36).

From: Clinical value of urinary cytokines/chemokines as prognostic markers in patients with crescentic glomerulonephritis

Urine cytokines/chemokines

Unadjusted

Adjusteda

OR (95% CI)

P

OR (95% CI)

P

ln(urine RANTES/creatinine)

1.99 (0.98–4.05)

0.06

1.94 (0.88–4.28)

0.10

ln(urine fractalkine/creatinine)

2.01 (0.77–5.24)

0.15

2.94 (0.91–9.44)

0.07

ln(urine IFN-γ/creatinine)

0.95 (0.46–2.00)

0.90

0.94 (0.39–2.28)

0.94

ln(urine IL-10/creatinine)

2.13 (0.91–4.99)

0.08

2.50 (1.01–6.21)

0.048

ln(urine IL-4/creatinine)

1.56 (0.56–4.32)

0.39

1.84 (0.60–5.68)

0.29

ln(urine IL-6/creatinine)

1.23 (0.75–2.02)

0.41

1.50 (0.79–2.84)

0.21

ln(urine MCP-1/creatinine)

2.18 (0.96–4.95)

0.06

2.27 (0.90–5.72)

0.08

ln(urine TNF-α/creatinine)

1.23 (0.91–1.66)

0.17

1.27 (0.93–1.76)

0.14

ln(urine VEGF/creatinine)

1.06 (0.46–2.46)

0.89

0.97 (0.39–2.38)

0.94

ln(urine BLC/creatinine)

1.20 (0.76–1.89)

0.44

1.47 (0.82–2.62)

0.20

  1. BLC, B lymphocyte chemokine; CI, confidence interval; IFN, interferon; IFTA, interstitial fibrosis tubular atrophy; IL, interleukin; MCP, monocyte chemoattractant protein; OR, odds ratio; RANTES, regulated on activation, normal T cell expressed and secreted; TNF, tumor necrosis factor; VEGF, vascular endothelial growth factor.
  2. aAdjusted for ln(eGFR) and tubular chronic change (IFTA score).
Back to article page